Medical Pharmacology Chapter 32: Hypothalamic and Pituitary Hormones
Physiological Consequences of Pituitary Tumors
|
|
Hormonal over production/under production
Pituitary tumors: most common syndromes due to:
Growth hormone excess
Gigantism, acromegaly
Prolactin excess
Galactorrhea and/or hypogonadism
ACTH-secreting tumors: Cushing's disease
TSH-secreting tumors: hyperthyroidism (rare)
Gonadotropin-secreting tumors: hypogonadism (paradoxical)
Large pituitary tumors
Hypopituitarism (due to gland compression; or pituitary stalk compression) may result in visual field disturbances possibly due to optic chiasm compression.
Hypopituitarism
Prolactin secretion increased
Significant Diagnostic Indication:
Diabetes insipidus ,due to vasopressin (AVP) deficiency.
Pituitary gland (hypophysis) resides within sella turcica of the sphenoid bone at the skull base (weight = between 0.4 and 0.8 grams)
Midsagittal section through human pituitary (above)
Sagittal section of a human pituitary, showing the relationship of its blood supply to the hypothalamic neurosecretory cells in the adenohypophysis (above)
Sagittal section of a human pituitary, showing the relationship of its blood supply to the neurosecretory cells of the supraoptic and paraventricular nuclei of the hypothalamus (above)
Pituitary gland components:
Anterior lobe (adenohypophysis)
Posterior lobe (neurohypophysis)
Separated from brain by diaphragma sella (dura mater extension) and by thin bone layers from the sphenoid sinus anteriorly and inferiorly
Sella lateral walls abut on the cavernous sinuses (containing internal carotid arteries & cranial nerves III, IV, V, and VI. Recurrent
Optic chiasm located slightly anterior to pituitary stalk -- just above diaphragma sella.
Reason why pituitary tumors result in visual field effects, cranial nerves palsies, sphenoid sinus invasion
|
1. cerebral peduncle |
Image source attribution: University of Manitoba Anatomy
Hypothalamus
Anterior extension to optic chiasm margin
Posterior extension including mammillary bodies
Separated from pituitary by the hypothalamic sulcus of the third ventricle.
Rounded inferior hypothalamic base: tuber cinereum
Base central portion (median eminence or infundibulum) formed by third ventricle floor, continuing inferiorly to form the pituitary stalk.
Hypothalamic releasing factors synthesized in neurons located along third ventricular margins.
Fibers from these neurons terminate in the median eminence adjacent to portal capillaries.
Neuronal cell bodies of supraoptic and periventricular hypothalamic nuclei produce vasopressin and oxytocin which are transported along nerve axons (supraopticohypophyseal and paraventriculohypophyseal tracts) to the posterior lobe.
Hypothalamic-anterior pituitary communication is chemically mediated:
Hypothalamic neuronal releasing factors flow through the portal system to stimulate or inhibit anterior pituitary hormone production
Anterior pituitary blood supply: (highest blood flow of any tissue, about 0.8mL/g/min.
Blood supplied by way of the hypothalamus:
Two derivatives of the internal carotid arteries, the superior hypophyseal arteries (SHA) terminate in median eminence,which resides outside the blood-brain barrier capillary network.
These capillaries exhibit a fenestrated endothelium which results in easy access to hypothalamic releasing hormones with the system regulated by vasoactive intestinal peptide, VIP.
Capillaries form 6-10 straight veins, the hypothalamic pituitary portal circulation, with the main blood supply to anterior lobe, supplying nutrients and hypothalamic factors.
Primary Reference: Fitzgerald, P.A. and Klonoff, D.C. Hypothalamic and Pituitary Hormones, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 603-618.
Primary Reference: Biller, Beverly M. K. and Daniels, Gilbert, H. Neuroendocrine Regulation and Diseases of the Anterior Pituitary and Hypothalamus, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 1972-1998
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |